BiotechTube
Home/Adicet Bio/Blake Aftab, Ph.D.
BA

Blake Aftab, Ph.D.

Chief Scientific Officer

Adicet Bio

Therapeutic Areas

Autoimmune DiseasesOncology

Adicet Bio Pipeline

DrugIndicationPhase
Prulacabtagene leucel (prula-cel, ADI-001)B-cell Mediated Autoimmune DiseasesPhase 1
ADI-001Relapsed/Refractory B-cell Non-Hodgkin's LymphomaPhase 1
Platform PipelineSolid Tumors & Hematological MalignanciesDiscovery/Preclinical

Leadership Team at Adicet Bio

CS
Chen Schor
President and Chief Executive Officer
JM
Julie Maltzman, M.D.
Chief Medical Officer
View full Adicet Bio profile